Acrodermatitis continua Hallopeau successfully treated by risankizumab

Authors :: Monika Arenbergerova
Petr Arenberger
Spyridon Gkalpakiotis
Jan Hugo
Petra Gkalpakioti
Source :: International Journal of Dermatology. 60
Publication Year :: 2020
Publisher :: Wiley, 2020.

Subjects :: medicine.medical_specialty
Risankizumab
Skin Diseases, Vesiculobullous
business.industry
Acrodermatitis
Antibodies, Monoclonal
Humans
Psoriasis
Medicine
Dermatology
business
Acrodermatitis continua hallopeau

Full Text Access

Tools